Readiness Assessment Optimisation Toolkit for GPs to adopt PDAC Tests
Research type
Research Study
Full title
A Readiness Assessment and Optimisation Toolkit to Support General Practices Prepare to Adopt New Non-Invasive Pancreatic Cancer Biomarker Tests
IRAS ID
330521
Contact name
Patrick Kierkegaard
Contact email
Duration of Study in the UK
0 years, 8 months, 31 days
Research summary
What are the aims of the study?
To develop a toolkit that will help assess general practices readiness to adopt specific types of novel pancreatic cancer biomarker tests and provide recommendations for optimisation.Why is this so relevant and important for people affected by pancreatic cancer?
Getting these tests into primary care will be difficult because many general practices may not be ready or able to use them. Patients living in deprived or rural areas may not have access to the tests. Surgeries may not have the trained staff or money available to use the tests. Our “toolkit” will find out if different types of general practices are able and ready to start using these new tests and identify what support they will need from the NHS to be prepared.Why is this project innovative in the field of pancreatic cancer?
There is no procedure in place that can specifically check and measure how ready general practices are to adopt new pancreatic cancer tests and identify what support and resources are needed to facilitate adoption.What are you planning to do?
We will talk to healthcare professionals, patients, carers, and key decision makers to find out what support and advice is needed so that doctors’ surgeries can prepare and plan to use the new tests.
We will hold focus groups with patients, carers, healthcare professionals, and key decision makers will discuss the results from the first part of the study and co-design the toolkit. We will make sure that our toolkit will have a real impact in primary care.REC name
Wales REC 4
REC reference
24/WA/0155
Date of REC Opinion
15 May 2024
REC opinion
Unfavourable Opinion